Terms: = Uterine cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
149 results:
1. EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.
Huang YH; Wang WL; Wang PH; Lee HT; Chang WW
Int J Biol Sci; 2024; 20(1):265-279. PubMed ID: 38164180
[TBL] [Abstract] [Full Text] [Related]
2. Upregulation of FAM83F by c-myc promotes cervical cancer growth and aerobic glycolysis via Wnt/β-catenin signaling activation.
Zhang C; Liu L; Li W; Li M; Zhang X; Zhang C; Yang H; Xie J; Pan W; Guo X; She P; Zhong L; Li T
Cell Death Dis; 2023 Dec; 14(12):837. PubMed ID: 38104106
[TBL] [Abstract] [Full Text] [Related]
3. LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and EMT in cervical cancer.
Cheng Z; Wang H; Yang Z; Li J; Chen X
BMC Cancer; 2023 Nov; 23(1):1128. PubMed ID: 37986152
[TBL] [Abstract] [Full Text] [Related]
4. Diminazene aceturate-induced cytotoxicity is associated with the deregulation of cell cycle signaling and downregulation of oncogenes Furin, c-myc, and FOXM1 in human cervical carcinoma Hela cells.
Gharbaran R; Sayibou Z; Atamturktur S; Ofosu-Mensah JJ; Soto J; Boodhan N; Kolya S; Onwumere O; Chang L; Somenarain L; Redenti S
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23527. PubMed ID: 37681557
[TBL] [Abstract] [Full Text] [Related]
5. Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Dou Y; Katsnelson L; Gritsenko MA; Hu Y; Reva B; Hong R; Wang YT; Kolodziejczak I; Lu RJ; Tsai CF; Bu W; Liu W; Guo X; An E; Arend RC; Bavarva J; Chen L; Chu RK; Czekański A; Davoli T; Demicco EG; DeLair D; Devereaux K; Dhanasekaran SM; Dottino P; Dover B; Fillmore TL; Foxall M; Hermann CE; Hiltke T; Hostetter G; Jędryka M; Jewell SD; Johnson I; Kahn AG; Ku AT; Kumar-Sinha C; Kurzawa P; Lazar AJ; Lazcano R; Lei JT; Li Y; Liao Y; Lih TM; Lin TT; Martignetti JA; Masand RP; Matkowski R; McKerrow W; Mesri M; Monroe ME; Moon J; Moore RJ; Nestor MD; Newton C; Omelchenko T; Omenn GS; Payne SH; Petyuk VA; Robles AI; Rodriguez H; Ruggles KV; Rykunov D; Savage SR; Schepmoes AA; Shi T; Shi Z; Tan J; Taylor M; Thiagarajan M; Wang JM; Weitz KK; Wen B; Williams CM; Wu Y; Wyczalkowski MA; Yi X; Zhang X; Zhao R; Mutch D; Chinnaiyan AM; Smith RD; Nesvizhskii AI; Wang P; Wiznerowicz M; Ding L; Mani DR; Zhang H; Anderson ML; Rodland KD; Zhang B; Liu T; Fenyö D;
Cancer Cell; 2023 Sep; 41(9):1586-1605.e15. PubMed ID: 37567170
[TBL] [Abstract] [Full Text] [Related]
6. WIF1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt/β-catenin signaling pathway.
Zhang B; Ji J; Hu M; Zhou X; Nie Q; Xu H; Jiang C; Fu Y; Li L
Am J Reprod Immunol; 2023 Aug; 90(2):e13743. PubMed ID: 37491917
[TBL] [Abstract] [Full Text] [Related]
7. PSME3 induces radioresistance and enhances aerobic glycolysis in cervical cancer by regulating PARP1.
Wei X; Sun K; Li S; Lin C; Wei Z
Tissue Cell; 2023 Aug; 83():102151. PubMed ID: 37467687
[TBL] [Abstract] [Full Text] [Related]
8. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway.
Zheng P; Wu Y; Wang Y; Hu F
Cell Signal; 2023 Sep; 109():110771. PubMed ID: 37329997
[TBL] [Abstract] [Full Text] [Related]
9. WIF1 was downregulated in cervical cancer due to promoter methylation.
Wang Y; Yuan S; Ma J; Liu H; Huang L; Zhang F; Wang X
Acta Biochim Pol; 2023 Jun; 70(2):419-423. PubMed ID: 37306343
[TBL] [Abstract] [Full Text] [Related]
10. The Functional Role and Regulatory Mechanism of FTO m
Yang Q; Al-Hendy A
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175660
[TBL] [Abstract] [Full Text] [Related]
11. miR-145 inhibits aerobic glycolysis and cell proliferation of cervical cancer by acting on myc.
Hu C; Liu T; Zhang W; Sun Y; Jiang D; Zhang X; Liu Y; Mao S; Xu Y; Pan J; Wang J; Huang Y; Yang S; Yang K
FASEB J; 2023 Apr; 37(4):e22839. PubMed ID: 36946075
[TBL] [Abstract] [Full Text] [Related]
12. Low-Dose Aspirin Has Antiproliferative and Apoptosis Effects in HPV16 Tumor Cells and Delays Tumor Development and Growth in an Experimental Model.
Zárate GDSF; Flores FLR; Burguete AI; Marina VM; Olea EG; Carranza CO; Melendrez CG; Morales VHB
Gynecol Obstet Invest; 2023; 88(3):150-158. PubMed ID: 36882036
[TBL] [Abstract] [Full Text] [Related]
13.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma.
Bayçelebi D; Kefeli M; Yıldız L; Karagöz F
Pol J Pathol; 2022; 73(3):233-243. PubMed ID: 36734438
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of the proteomic landscape of HPV E7‑induced alterations in human keratinocytes reveal therapeutically relevant pathways for cervical cancer.
Gandhi S; Mohamad Razif MF; Othman S; Chakraborty S; Nor Rashid N
Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36633133
[TBL] [Abstract] [Full Text] [Related]
16. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
Zhang X; Wang M; Zhang Y; Yang J; Duan W
Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
[TBL] [Abstract] [Full Text] [Related]
17. Paiteling induces apoptosis of cervical cancer cells by down-regulation of the E6/E7-Pi3k/Akt pathway: A network pharmacology.
Liu Y; Zheng P; Jiao T; Zhang M; Wu Y; Zhang X; Wang S; Zhao Z
J Ethnopharmacol; 2023 Apr; 305():116062. PubMed ID: 36535331
[TBL] [Abstract] [Full Text] [Related]
18. Deregulation of SPOP in cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract] [Full Text] [Related]
19. Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine Neoplasia: A Report of 14 Cases.
Ordulu Z; Mino-Kenudson M; Young RH; Van de Vijver K; Zannoni GF; Félix A; Burandt E; Wong A; Nardi V; Oliva E
Am J Surg Pathol; 2022 Dec; 46(12):1670-1681. PubMed ID: 36069807
[TBL] [Abstract] [Full Text] [Related]
20. Small Cell and Other Rare Histologic Types of Cervical cancer.
Marchocki Z; Swift B; Covens A
Curr Oncol Rep; 2022 Nov; 24(11):1531-1539. PubMed ID: 35947285
[TBL] [Abstract] [Full Text] [Related]
[Next]
